If you do decide to discontinue, a planned, supervised approach will give you the best chance of a smooth transition with minimal disruption to your quality of life
The FDA uses a labeling system to provide information about the safety of drugs during pregnancy and breastfeeding
As demand for effective and reliable weight-loss solutions grows, Novos ability to deliver strong efficacy, consistent availability, and improved affordability positions it ahead of Eli Lilly in the obesity treatment market
n the SURPASS-CVOT trial, tirzepatide produced approximately 12% weight loss compared with 5% for dulaglutide, alongside nearly double the HbA1c reduction
If youre experiencing indigestion or nausea while on GLP-1 therapy, you may try eating smaller, more frequent meals throughout the day
The Wegovy (semaglutide) tablet is taken daily and is for obese adults with a body mass index (BMI) of 30 or above